|
Afimetoran Clinical Trials
1 actively recruiting trial across 1 location
Also known as: BLN-256
Pipeline
Phase 2/3: 1
Top Sponsors
- Beeline Medicines Corporation1
Indications
- Systematic Lupus Erythematosus1
- Cutaneous Lupus Erythematosus (CLE)1
- Lupus1
San Diego, California1 trial
Study of Afimetoran in Adults With Cutaneous Lupus Erythematosus
University Clinical Trials
Phase 2/3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.